eXoZymes, Inc. (EXOZ)
NASDAQ: EXOZ · Real-Time Price · USD
13.40
-0.50 (-3.60%)
May 30, 2025, 4:00 PM - Market closed
eXoZymes Employees
eXoZymes had 31 employees as of December 31, 2024. The number of employees increased by 2 or 6.90% compared to the previous year.
Employees
31
Change (1Y)
2
Growth (1Y)
6.90%
Revenue / Employee
n/a
Profits / Employee
-$216,429
Market Cap
112.13M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 31 | 2 | 6.90% |
| Dec 31, 2023 | 29 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
EXOZ News
- 14 days ago - eXoZymes Highlights Scalable Biomanufacturing Platform and First Spinout, NCTx, on Grow Everything Podcast - Accesswire
- 18 days ago - eXoZymes Provides First Quarter 2025 and NCTx Subsidiary Update at 5PM EST Today - Accesswire
- 23 days ago - eXoZymes to Host First Quarter 2025 and Subsidiary NCTx Update on Monday May 12, 2025, at 5PM EST - Accesswire
- 24 days ago - eXoZymes Launches Subsidiary, NCTx, to Unlock a Promising Compound for Gut and Liver Health - Accesswire
- 5 weeks ago - Bringing clarity and precision to the cell-free space by introducing exozymes - GlobeNewsWire
- 7 weeks ago - BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant - GlobeNewsWire
- 2 months ago - eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO - GlobeNewsWire
- 2 months ago - eXoZymes Provides Fourth Quarter and Full Year 2024 Update - GlobeNewsWire